CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Terns Pharmaceuticals
TERN
$632M
| $46.4K | 0.01% |
7,147
+5,587
| +358% | +$36.3K |
|
377
SIGA Technologies
SIGA
$603M
| $46.1K | 0.01% |
8,225
+6,404
| +352% | +$35.9K |
|
378
Harrow
HROW
$1.37B
| $45.5K | 0.01% |
4,063
+3,155
| +347% | +$35.3K |
|
|
ITOS
379
DELISTED
iTeos Therapeutics
ITOS
| $45.3K | 0.01% |
4,140
+3,216
| +348% | +$35.2K |
|
|
WBA
380
DELISTED
Walgreens Boots Alliance
WBA
| $44.8K | 0.01% |
1,715
-1,502
| -47% | -$39.2K |
|
381
Lexicon Pharmaceuticals
LXRX
$396M
| $43.3K | 0.01% |
28,329
+22,043
| +351% | +$33.7K |
|
382
Nautilus Biotechnolgy
NAUT
$83.5M
| $43.2K | 0.01% |
14,452
+11,248
| +351% | +$33.6K |
|
383
Voyager Therapeutics
VYGR
$235M
| $43K | 0.01% |
+5,093
| New | +$43K |
|
384
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $42.9K | 0.01% |
12,880
+10,454
| +431% | +$34.8K |
|
385
uniQure
QURE
$985M
| $42.4K | 0.01% |
6,258
+4,315
| +222% | +$29.2K |
|
386
SiriusXM
SIRI
$8.1B
| $42.1K | 0.01% |
770
-662
| -46% | -$36.2K |
|
387
Ocular Therapeutix
OCUL
$2.37B
| $41K | 0.01% |
9,192
+7,152
| +351% | +$31.9K |
|
388
Mineralys Therapeutics
MLYS
$2.7B
| $40.9K | 0.01% |
+4,750
| New | +$40.9K |
|
389
Unity
U
$18.5B
| $39.3K | 0.01% |
961
| – | – |
|
|
AMRN
390
Amarin Corp
AMRN
$317M
| $38.8K | 0.01% |
2,230
+1,736
| +351% | +$30.2K |
|
391
Precigen
PGEN
$1.3B
| $38.6K | 0.01% |
28,788
+22,227
| +339% | +$29.8K |
|
392
Taysha Gene Therapies
TSHA
$917M
| $38.3K | 0.01% |
+21,622
| New | +$38.3K |
|
393
Xeris Biopharma Holdings
XERS
$1.27B
| $37.5K | 0.01% |
15,973
+12,432
| +351% | +$29.2K |
|
394
Erasca
ERAS
$457M
| $37.2K | 0.01% |
17,472
+13,597
| +351% | +$29K |
|
395
Align Technology
ALGN
$10.1B
| $36.4K | 0.01% |
133
-285
| -68% | -$78.1K |
|
396
Arcutis Biotherapeutics
ARQT
$2.06B
| $35.3K | 0.01% |
10,920
+9,330
| +587% | +$30.1K |
|
397
Y-mAbs Therapeutics
YMAB
$390M
| $34.4K | 0.01% |
+5,050
| New | +$34.4K |
|
398
Humacyte
HUMA
$226M
| $34K | 0.01% |
11,986
+9,325
| +350% | +$26.5K |
|
|
EXAI
399
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $33.6K | 0.01% |
5,245
+4,104
| +360% | +$26.3K |
|
|
ME
400
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $32.9K | 0.01% |
1,802
+1,411
| +361% | +$25.8K |
|